Pomelo Care has been selected as a spoke for the Investor Catalyst Hub, a regional hub of ARPANET-H, a nationwide health innovation network launched by the Advanced Research Projects Agency for Health (ARPA-H).
Pomelo joins a dynamic, nationwide network of organizations aligned to ARPA-H’s overarching mission to improve health outcomes through the following research focus areas: health science futures, proactive health, scalable solutions, and resilient systems. Investor Catalyst Hub spokes represent a broad spectrum of expertise, geographic diversity, and community perspectives.
This collaboration aligns with Pomelo’s work to address the maternity healthcare crisis in the U.S., where we provide comprehensive care and high-touch support for women across the entire maternal journey, from preconception and pregnancy to birth, postpartum, and the first year of their infant’s life.
Based in the Greater Boston area and managed by VentureWell, the Investor Catalyst Hub seeks to accelerate the commercialization of groundbreaking and accessible biomedical solutions. It utilizes an innovative hub-and-spoke model designed to reach a wide range of nonprofit organizations and Minority-Serving Institutions, with the ultimate aim of delivering scalable healthcare outcomes for all Americans.
As an Investor Catalyst Hub spoke, Pomelo now gains access to potential funding and flexible contracting for faster award execution compared to traditional government contracts. Spoke membership also offers Pomelo opportunities to provide input on ARPA-H challenge areas and priorities, along with access to valuable networking opportunities and a robust resource library. The spoke network will continue to grow as the Investor Catalyst Hub expands its efforts, with applications being selected on a rolling basis.
Thank you to the Investor Catalyst Hub team for including Pomelo in this important work. Other interested organizations can visit https://investorcatalysthub.org/ to learn more or submit a membership application.